TY - JOUR AU - Palella, F. J. AU - Delaney, K. M. AU - Moorman, A. C. AU - Loveless, M. O. AU - Fuhrer, J. AU - Satten, G. A. AU - Aschman, D. J. AU - Holmberg, S. D. PY - 1998 DA - 1998// TI - Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient study investigators JO - N Engl J Med VL - 338 UR - https://doi.org/10.1056/NEJM199803263381301 DO - 10.1056/NEJM199803263381301 ID - Palella1998 ER - TY - JOUR AU - Boyer, J. C. AU - Bebenek, K. AU - Kunkel, T. A. PY - 1992 DA - 1992// TI - Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates JO - Proc Natl Acad Sci USA VL - 89 UR - https://doi.org/10.1073/pnas.89.15.6919 DO - 10.1073/pnas.89.15.6919 ID - Boyer1992 ER - TY - JOUR AU - Ji, J. P. AU - Loeb, L. A. PY - 1992 DA - 1992// TI - Fidelity of HIV-1 reverse transcriptase copying RNA in vitro JO - Biochemistry VL - 31 UR - https://doi.org/10.1021/bi00119a002 DO - 10.1021/bi00119a002 ID - Ji1992 ER - TY - JOUR AU - Menendez-Arias, L. PY - 2002 DA - 2002// TI - Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases JO - Prog Nucleic Acid Res Mol Biol VL - 71 UR - https://doi.org/10.1016/S0079-6603(02)71042-8 DO - 10.1016/S0079-6603(02)71042-8 ID - Menendez-Arias2002 ER - TY - JOUR AU - Bonhoeffer, S. AU - May, R. M. AU - Shaw, G. M. AU - Nowak, M. A. PY - 1997 DA - 1997// TI - Virus dynamics and drug therapy JO - Proc Natl Acad Sci USA VL - 94 UR - https://doi.org/10.1073/pnas.94.13.6971 DO - 10.1073/pnas.94.13.6971 ID - Bonhoeffer1997 ER - TY - JOUR AU - Nowak, M. A. AU - Bonhoeffer, S. AU - Shaw, G. M. AU - May, R. M. PY - 1997 DA - 1997// TI - Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations JO - J Theor Biol VL - 184 UR - https://doi.org/10.1006/jtbi.1996.0307 DO - 10.1006/jtbi.1996.0307 ID - Nowak1997 ER - TY - JOUR AU - Nijhuis, M. AU - Boucher, C. A. AU - Schipper, P. AU - Leitner, T. AU - Schuurman, R. AU - Albert, J. PY - 1998 DA - 1998// TI - Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.24.14441 DO - 10.1073/pnas.95.24.14441 ID - Nijhuis1998 ER - TY - JOUR AU - Duffy, S. AU - Shackelton, L. A. AU - Holmes, E. C. PY - 2008 DA - 2008// TI - Rates of evolutionary change in viruses: patterns and determinants JO - Nat Rev Genet VL - 9 UR - https://doi.org/10.1038/nrg2323 DO - 10.1038/nrg2323 ID - Duffy2008 ER - TY - JOUR AU - Alexander, H. K. AU - Bonhoeffer, S. PY - 2012 DA - 2012// TI - Pre-existence and emergence of drug resistance in a generalized model of intra-host viral dynamics JO - Epidemics VL - 4 UR - https://doi.org/10.1016/j.epidem.2012.10.001 DO - 10.1016/j.epidem.2012.10.001 ID - Alexander2012 ER - TY - JOUR AU - Espeseth, A. S. AU - Felock, P. AU - Wolfe, A. AU - Witmer, M. AU - Grobler, J. AU - Anthony, N. AU - Egbertson, M. AU - Melamed, J. Y. AU - Young, S. AU - Hamill, T. PY - 2000 DA - 2000// TI - HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase JO - Proc Natl Acad Sci USA VL - 97 UR - https://doi.org/10.1073/pnas.200139397 DO - 10.1073/pnas.200139397 ID - Espeseth2000 ER - TY - JOUR AU - Hare, S. AU - Gupta, S. S. AU - Valkov, E. AU - Engelman, A. AU - Cherepanov, P. PY - 2010 DA - 2010// TI - Retroviral intasome assembly and inhibition of DNA strand transfer JO - Nature VL - 464 UR - https://doi.org/10.1038/nature08784 DO - 10.1038/nature08784 ID - Hare2010 ER - TY - JOUR AU - Krishnan, L. AU - Li, X. AU - Naraharisetty, H. L. AU - Hare, S. AU - Cherepanov, P. AU - Engelman, A. PY - 2010 DA - 2010// TI - Structure-based modeling of the functional HIV-1 intasome and its inhibition JO - Proc Natl Acad Sci USA VL - 107 UR - https://doi.org/10.1073/pnas.1002346107 DO - 10.1073/pnas.1002346107 ID - Krishnan2010 ER - TY - STD TI - ISENTRESS™ (raltegravir) for treatment of HIV (NDA 22145 S036). FDA May 31 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022145s036,203045s013,205786s004lbl.pdf. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022145s036%2c203045s013%2c205786s004lbl.pdf ID - ref13 ER - TY - JOUR AU - Messiaen, P. AU - Wensing, A. M. AU - Fun, A. AU - Nijhuis, M. AU - Brusselaers, N. AU - Vandekerckhove, L. PY - 2013 DA - 2013// TI - Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0052562 DO - 10.1371/journal.pone.0052562 ID - Messiaen2013 ER - TY - JOUR AU - Rockstroh, J. K. AU - DeJesus, E. AU - Lennox, J. L. AU - Yazdanpanah, Y. AU - Saag, M. S. AU - Wan, H. AU - Rodgers, A. J. AU - Walker, M. L. AU - Miller, M. AU - DiNubile, M. J. PY - 2013 DA - 2013// TI - Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK JO - J Acquir Immune Defic Syndr VL - 63 UR - https://doi.org/10.1097/QAI.0b013e31828ace69 DO - 10.1097/QAI.0b013e31828ace69 ID - Rockstroh2013 ER - TY - JOUR AU - Cooper, D. A. AU - Steigbigel, R. T. AU - Gatell, J. M. AU - Rockstroh, J. K. AU - Katlama, C. AU - Yeni, P. AU - Lazzarin, A. AU - Clotet, B. AU - Kumar, P. N. AU - Eron, J. E. PY - 2008 DA - 2008// TI - Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708978 DO - 10.1056/NEJMoa0708978 ID - Cooper2008 ER - TY - STD TI - Miller MD, Danovich R, Ke Y, Witmer M, Zhao J, Harvey C, Nguyen BY, Hazuda DJ: Longitudinal analysis of resistance to the HIV-1 integrase inhibitor raltegravir: results from P005 a phase 2 study in treatment experienced patients. In: XVII international HIV drug resistance workshop, Sitges, Spain. 2008. ID - ref17 ER - TY - JOUR AU - Johnson, V. A. AU - Brun-Vezinet, F. AU - Clotet, B. AU - Gunthard, H. F. AU - Kuritzkes, D. R. AU - Pillay, D. AU - Schapiro, J. M. AU - Richman, D. D. PY - 2010 DA - 2010// TI - Update of the drug resistance mutations in HIV-1: December 2010 JO - Top HIV Med VL - 18 ID - Johnson2010 ER - TY - JOUR AU - Fransen, S. AU - Gupta, S. AU - Danovich, R. AU - Hazuda, D. AU - Miller, M. AU - Witmer, M. AU - Petropoulos, C. J. AU - Huang, W. PY - 2009 DA - 2009// TI - Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways JO - J Virol VL - 83 UR - https://doi.org/10.1128/JVI.01168-09 DO - 10.1128/JVI.01168-09 ID - Fransen2009 ER - TY - JOUR AU - Malet, I. AU - Delelis, O. AU - Valantin, M. A. AU - Montes, B. AU - Soulie, C. AU - Wirden, M. AU - Tchertanov, L. AU - Peytavin, G. AU - Reynes, J. AU - Mouscadet, J. F. PY - 2008 DA - 2008// TI - Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro JO - Antimicrob Agents Chemother VL - 52 UR - https://doi.org/10.1128/AAC.01228-07 DO - 10.1128/AAC.01228-07 ID - Malet2008 ER - TY - JOUR AU - Nakahara, K. AU - Wakasa-Morimoto, C. AU - Kobayashi, M. AU - Miki, S. AU - Noshi, T. AU - Seki, T. AU - Kanamori-Koyama, M. AU - Kawauchi, S. AU - Suyama, A. AU - Fujishita, T. PY - 2009 DA - 2009// TI - Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics JO - Antivir Res VL - 81 UR - https://doi.org/10.1016/j.antiviral.2008.10.007 DO - 10.1016/j.antiviral.2008.10.007 ID - Nakahara2009 ER - TY - JOUR AU - Quercia, R. AU - Dam, E. AU - Perez-Bercoff, D. AU - Clavel, F. PY - 2009 DA - 2009// TI - Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes JO - J Virol VL - 83 UR - https://doi.org/10.1128/JVI.00894-09 DO - 10.1128/JVI.00894-09 ID - Quercia2009 ER - TY - JOUR AU - Fun, A. AU - Baelen, K. AU - Lelyveld, S. F. AU - Schipper, P. J. AU - Stuyver, L. J. AU - Wensing, A. M. AU - Nijhuis, M. PY - 2010 DA - 2010// TI - Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity JO - J Antimicrob Chemother VL - 65 UR - https://doi.org/10.1093/jac/dkq319 DO - 10.1093/jac/dkq319 ID - Fun2010 ER - TY - JOUR AU - Blanco, J. L. AU - Varghese, V. AU - Rhee, S. Y. AU - Gatell, J. M. AU - Shafer, R. W. PY - 2011 DA - 2011// TI - HIV-1 integrase inhibitor resistance and its clinical implications JO - J Infect Dis VL - 203 UR - https://doi.org/10.1093/infdis/jir025 DO - 10.1093/infdis/jir025 ID - Blanco2011 ER - TY - JOUR AU - Anstett, K. AU - Brenner, B. AU - Mesplede, T. AU - Wainberg, M. A. PY - 2017 DA - 2017// TI - HIV drug resistance against strand transfer integrase inhibitors JO - Retrovirology VL - 14 UR - https://doi.org/10.1186/s12977-017-0360-7 DO - 10.1186/s12977-017-0360-7 ID - Anstett2017 ER - TY - JOUR AU - Malet, I. AU - Delelis, O. AU - Soulie, C. AU - Wirden, M. AU - Tchertanov, L. AU - Mottaz, P. AU - Peytavin, G. AU - Katlama, C. AU - Mouscadet, J. F. AU - Calvez, V. AU - Marcelin, A. G. PY - 2009 DA - 2009// TI - Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients JO - J Antimicrob Chemother VL - 63 UR - https://doi.org/10.1093/jac/dkp014 DO - 10.1093/jac/dkp014 ID - Malet2009 ER - TY - JOUR AU - Reigadas, S. AU - Anies, G. AU - Masquelier, B. AU - Calmels, C. AU - Stuyver, L. J. AU - Parissi, V. AU - Fleury, H. AU - Andreola, M. L. PY - 2010 DA - 2010// TI - The HIV-1 integrase mutations Y143C/R are an alternative pathway for resistance to Raltegravir and impact the enzyme functions JO - PLoS ONE VL - 5 UR - https://doi.org/10.1371/journal.pone.0010311 DO - 10.1371/journal.pone.0010311 ID - Reigadas2010 ER - TY - JOUR AU - Silva, D. AU - Wesenbeeck, L. AU - Breilh, D. AU - Reigadas, S. AU - Anies, G. AU - Baelen, K. AU - Morlat, P. AU - Neau, D. AU - Dupon, M. AU - Wittkop, L. PY - 2010 DA - 2010// TI - HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens JO - J Antimicrob Chemother VL - 65 UR - https://doi.org/10.1093/jac/dkq099 DO - 10.1093/jac/dkq099 ID - Silva2010 ER - TY - JOUR AU - Mukherjee, R. AU - Jensen, S. T. AU - Male, F. AU - Bittinger, K. AU - Hodinka, R. L. AU - Miller, M. D. AU - Bushman, F. D. PY - 2011 DA - 2011// TI - Switching between raltegravir resistance pathways analyzed by deep sequencing JO - AIDS VL - 25 UR - https://doi.org/10.1097/QAD.0b013e32834b34de DO - 10.1097/QAD.0b013e32834b34de ID - Mukherjee2011 ER - TY - JOUR AU - Goethals, O. AU - Vos, A. AU - Ginderen, M. AU - Geluykens, P. AU - Smits, V. AU - Schols, D. AU - Hertogs, K. AU - Clayton, R. PY - 2010 DA - 2010// TI - Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles JO - Virology VL - 402 UR - https://doi.org/10.1016/j.virol.2010.03.034 DO - 10.1016/j.virol.2010.03.034 ID - Goethals2010 ER - TY - JOUR AU - Metifiot, M. AU - Vandegraaff, N. AU - Maddali, K. AU - Naumova, A. AU - Zhang, X. AU - Rhodes, D. AU - Marchand, C. AU - Pommier, Y. PY - 2011 DA - 2011// TI - Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143 JO - Aids VL - 25 UR - https://doi.org/10.1097/QAD.0b013e3283473599 DO - 10.1097/QAD.0b013e3283473599 ID - Metifiot2011 ER - TY - JOUR AU - Castagna, A. AU - Maggiolo, F. AU - Penco, G. AU - Wright, D. AU - Mills, A. AU - Grossberg, R. AU - Molina, J. M. AU - Chas, J. AU - Durant, J. AU - Moreno, S. PY - 2014 DA - 2014// TI - Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jiu051 DO - 10.1093/infdis/jiu051 ID - Castagna2014 ER - TY - JOUR AU - Akil, B. AU - Blick, G. AU - Hagins, D. P. AU - Ramgopal, M. N. AU - Richmond, G. J. AU - Samuel, R. M. AU - Givens, N. AU - Vavro, C. AU - Song, I. H. AU - Wynne, B. AU - Ait-Khaled, M. PY - 2015 DA - 2015// TI - Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study JO - Antivir Ther VL - 20 UR - https://doi.org/10.3851/IMP2878 DO - 10.3851/IMP2878 ID - Akil2015 ER - TY - JOUR AU - Hofstra, L. M. AU - Nijhuis, M. AU - Mudrikova, T. AU - Fun, A. AU - Schipper, P. AU - Schneider, M. AU - Wensing, A. PY - 2014 DA - 2014// TI - Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses JO - J Int AIDS Soc VL - 17 UR - https://doi.org/10.7448/IAS.17.4.19755 DO - 10.7448/IAS.17.4.19755 ID - Hofstra2014 ER - TY - STD TI - Seki T, Kobayashi M, Wakasa-Morimoto C, Yoshinaga T, Sato A, Fujiwara T, Underwood MR, Garvey EP, Johns BA: S/GSK1349572 is a potent next generation HIV integrase inhibitor and demonstrates a superior resistance profile substantiated with 60 integrase mutant molecular clones. In: 17th conference on retroviruses and opportunistic infections, San Francisco, CA, USA. 2010. ID - ref35 ER - TY - JOUR AU - Brenner, B. G. AU - Wainberg, M. A. PY - 2017 DA - 2017// TI - Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance JO - Virus Res VL - 239 UR - https://doi.org/10.1016/j.virusres.2016.07.006 DO - 10.1016/j.virusres.2016.07.006 ID - Brenner2017 ER - TY - JOUR AU - Laskey, S. B. AU - Siliciano, R. F. PY - 2016 DA - 2016// TI - Quantitative evaluation of the antiretroviral efficacy of dolutegravir JO - JCI Insight VL - 1 UR - https://doi.org/10.1172/jci.insight.90033 DO - 10.1172/jci.insight.90033 ID - Laskey2016 ER - TY - JOUR AU - Malet, I. AU - Gimferrer Arriaga, L. AU - Artese, A. AU - Costa, G. AU - Parrotta, L. AU - Alcaro, S. AU - Delelis, O. AU - Tmeizeh, A. AU - Katlama, C. AU - Valantin, M. A. PY - 2014 DA - 2014// TI - New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors JO - J Antimicrob Chemother VL - 69 UR - https://doi.org/10.1093/jac/dku095 DO - 10.1093/jac/dku095 ID - Malet2014 ER - TY - JOUR AU - Brenner, B. G. AU - Thomas, R. AU - Blanco, J. L. AU - Ibanescu, R. I. AU - Oliveira, M. AU - Mesplede, T. AU - Golubkov, O. AU - Roger, M. AU - Garcia, F. AU - Martinez, E. AU - Wainberg, M. A. PY - 2016 DA - 2016// TI - Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors JO - J Antimicrob Chemother VL - 71 UR - https://doi.org/10.1093/jac/dkw071 DO - 10.1093/jac/dkw071 ID - Brenner2016 ER - TY - JOUR AU - Liu, J. AU - Miller, M. D. AU - Danovich, R. M. AU - Vandergrift, N. AU - Cai, F. AU - Hicks, C. B. AU - Hazuda, D. J. AU - Gao, F. PY - 2010 DA - 2010// TI - Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.01492-10 DO - 10.1128/AAC.01492-10 ID - Liu2010 ER - TY - JOUR AU - Charpentier, C. AU - Laureillard, D. AU - Piketty, C. AU - Tisserand, P. AU - Batisse, D. AU - Karmochkine, M. AU - Si-Mohamed, A. AU - Weiss, L. PY - 2010 DA - 2010// TI - High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors JO - AIDS VL - 24 UR - https://doi.org/10.1097/QAD.0b013e3283367796 DO - 10.1097/QAD.0b013e3283367796 ID - Charpentier2010 ER - TY - JOUR AU - Codoner, F. M. AU - Pou, C. AU - Thielen, A. AU - Garcia, F. AU - Delgado, R. AU - Dalmau, D. AU - Santos, J. R. AU - Buzon, M. J. AU - Martinez-Picado, J. AU - Alvarez-Tejado, M. PY - 2010 DA - 2010// TI - Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure JO - Antivir Res VL - 88 UR - https://doi.org/10.1016/j.antiviral.2010.09.016 DO - 10.1016/j.antiviral.2010.09.016 ID - Codoner2010 ER - TY - JOUR AU - Johnson, J. A. AU - Geretti, A. M. PY - 2010 DA - 2010// TI - Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution JO - J Antimicrob Chemother VL - 65 UR - https://doi.org/10.1093/jac/dkq139 DO - 10.1093/jac/dkq139 ID - Johnson2010 ER - TY - JOUR AU - Li, J. Z. AU - Paredes, R. AU - Ribaudo, H. J. AU - Svarovskaia, E. S. AU - Metzner, K. J. AU - Kozal, M. J. AU - Hullsiek, K. H. AU - Balduin, M. AU - Jakobsen, M. R. AU - Geretti, A. M. PY - 2011 DA - 2011// TI - Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.375 DO - 10.1001/jama.2011.375 ID - Li2011 ER - TY - JOUR AU - Kobayashi, M. AU - Nakahara, K. AU - Seki, T. AU - Miki, S. AU - Kawauchi, S. AU - Suyama, A. AU - Wakasa-Morimoto, C. AU - Kodama, M. AU - Endoh, T. AU - Oosugi, E. PY - 2008 DA - 2008// TI - Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants JO - Antivir Res VL - 80 UR - https://doi.org/10.1016/j.antiviral.2008.06.012 DO - 10.1016/j.antiviral.2008.06.012 ID - Kobayashi2008 ER - TY - JOUR AU - Hu, Z. AU - Kuritzkes, D. R. PY - 2010 DA - 2010// TI - Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness JO - J Acquir Immune Defic Syndr VL - 55 UR - https://doi.org/10.1097/QAI.0b013e3181e9a87a DO - 10.1097/QAI.0b013e3181e9a87a ID - Hu2010 ER - TY - JOUR AU - Weir, J. T. AU - Haddrath, O. AU - Robertson, H. A. AU - Colbourne, R. M. AU - Baker, A. J. PY - 2016 DA - 2016// TI - Explosive ice age diversification of kiwi JO - Proc Natl Acad Sci USA VL - 113 UR - https://doi.org/10.1073/pnas.1603795113 DO - 10.1073/pnas.1603795113 ID - Weir2016 ER - TY - JOUR AU - Halliday, T. J. D. AU - Goswami, A. PY - 2016 DA - 2016// TI - Eutherian morphological disparity across the end-Cretaceous mass extinction JO - Biol J Lin Soc VL - 118 UR - https://doi.org/10.1111/bij.12731 DO - 10.1111/bij.12731 ID - Halliday2016 ER - TY - JOUR AU - Charpentier, C. AU - Karmochkine, M. AU - Laureillard, D. AU - Tisserand, P. AU - Belec, L. AU - Weiss, L. AU - Si-Mohamed, A. AU - Piketty, C. PY - 2008 DA - 2008// TI - Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy JO - HIV Med VL - 9 UR - https://doi.org/10.1111/j.1468-1293.2008.00628.x DO - 10.1111/j.1468-1293.2008.00628.x ID - Charpentier2008 ER - TY - STD TI - Goodman D, Hluhanich R, Waters J, Margot NA, Fransen S, Gupta S, Huang W, Parkin N, Borroto-Esoda K, Svarovskaia ES, et al: Integrase inhibitor resistance involves complex interactions among primary and secondary resistance mutations: a novel mutation L68V/I associates with E92Q and increases resistance. In: XVII international HIV drug resistance workshop, Sitges, Spain. 2008. ID - ref50 ER - TY - JOUR AU - Markowitz, M. AU - Nguyen, B. Y. AU - Gotuzzo, E. AU - Mendo, F. AU - Ratanasuwan, W. AU - Kovacs, C. AU - Prada, G. AU - Morales-Ramirez, J. O. AU - Crumpacker, C. S. AU - Isaacs, R. D. PY - 2007 DA - 2007// TI - Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study JO - J Acquir Immune Defic Syndr VL - 46 UR - https://doi.org/10.1097/QAI.0b013e318157131c DO - 10.1097/QAI.0b013e318157131c ID - Markowitz2007 ER - TY - JOUR AU - Sichtig, N. AU - Sierra, S. AU - Kaiser, R. AU - Daumer, M. AU - Reuter, S. AU - Schulter, E. AU - Altmann, A. AU - Fatkenheuer, G. AU - Dittmer, U. AU - Pfister, H. AU - Esser, S. PY - 2009 DA - 2009// TI - Evolution of raltegravir resistance during therapy JO - J Antimicrob Chemother VL - 64 UR - https://doi.org/10.1093/jac/dkp153 DO - 10.1093/jac/dkp153 ID - Sichtig2009 ER - TY - STD TI - Team RDC: R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org. 2008. UR - http://www.R-project.org ID - ref53 ER - TY - JOUR AU - Brodin, J. AU - Mild, M. AU - Hedskog, C. AU - Sherwood, E. AU - Leitner, T. AU - Andersson, B. AU - Albert, J. PY - 2013 DA - 2013// TI - PCR-induced transitions are the major source of error in cleaned ultra-deep pyrosequencing data JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0070388 DO - 10.1371/journal.pone.0070388 ID - Brodin2013 ER - TY - JOUR AU - Hedskog, C. AU - Mild, M. AU - Jernberg, J. AU - Sherwood, E. AU - Bratt, G. AU - Leitner, T. AU - Lundeberg, J. AU - Andersson, B. AU - Albert, J. PY - 2010 DA - 2010// TI - Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing JO - PLoS ONE VL - 5 UR - https://doi.org/10.1371/journal.pone.0011345 DO - 10.1371/journal.pone.0011345 ID - Hedskog2010 ER - TY - JOUR AU - Tsibris, A. M. AU - Korber, B. AU - Arnaout, R. AU - Russ, C. AU - Lo, C. C. AU - Leitner, T. AU - Gaschen, B. AU - Theiler, J. AU - Paredes, R. AU - Su, Z. PY - 2009 DA - 2009// TI - Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0005683 DO - 10.1371/journal.pone.0005683 ID - Tsibris2009 ER - TY - JOUR AU - Katoh, K. AU - Asimenos, G. AU - Toh, H. PY - 2009 DA - 2009// TI - Multiple alignment of DNA sequences with MAFFT JO - Methods Mol Biol VL - 537 UR - https://doi.org/10.1007/978-1-59745-251-9_3 DO - 10.1007/978-1-59745-251-9_3 ID - Katoh2009 ER - TY - JOUR AU - Paradis, E. AU - Claude, J. AU - Strimmer, K. PY - 2004 DA - 2004// TI - APE: analyses of phylogenetics and evolution in R language JO - Bioinformatics VL - 20 UR - https://doi.org/10.1093/bioinformatics/btg412 DO - 10.1093/bioinformatics/btg412 ID - Paradis2004 ER - TY - JOUR AU - Butts, S. F. AU - Owen, C. AU - Mainigi, M. AU - Senapati, S. AU - Seifer, D. B. AU - Dokras, A. PY - 2014 DA - 2014// TI - Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011 JO - Fertil Steril VL - 102 UR - https://doi.org/10.1016/j.fertnstert.2014.06.043 DO - 10.1016/j.fertnstert.2014.06.043 ID - Butts2014 ER - TY - JOUR AU - Maarseveen, N. M. AU - Huigen, M. C. AU - Jong, D. AU - Smits, A. M. AU - Boucher, C. A. AU - Nijhuis, M. PY - 2006 DA - 2006// TI - A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and/or reverse transcriptase variants JO - J Virol Methods VL - 133 UR - https://doi.org/10.1016/j.jviromet.2005.11.008 DO - 10.1016/j.jviromet.2005.11.008 ID - Maarseveen2006 ER - TY - JOUR AU - Boucher, C. A. AU - Keulen, W. AU - Bommel, T. AU - Nijhuis, M. AU - Jong, D. AU - Jong, M. D. AU - Schipper, P. AU - Back, N. K. PY - 1996 DA - 1996// TI - Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay JO - Antimicrob Agents Chemother VL - 40 ID - Boucher1996 ER -